Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin in Cervical Dystonia
NCT00407030Phase 3Completed
- Sponsor
- Merz
- Start
- Jul 2006
- Primary completion
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of incobotulinumtoxinA in cervical dystonia (CD), sponsored by Merz. Started Jul 2006; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT00407030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407030.